Extended-release injectable naltrexone (XR-NTX): a response to clinical issues raised by Brewer & Streel.
Saved in:
| Title: | Extended-release injectable naltrexone (XR-NTX): a response to clinical issues raised by Brewer & Streel. |
|---|---|
| Authors: | Jarvis BP; Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Holtyn AF; Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Subramaniam S; Department of Psychology and Child Development, California State University, Stanislaus, Turlock, CA, USA., Tompkins DA; Department of Psychiatry, University of California San Francisco School of Medicine Ringgold standard institution, San Francisco, CA, USA., Oga EA; Center for Applied Public Health Research, RTI International, Rockville, MD, USA., Bigelow G; Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Silverman K; Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA. |
| Source: | Addiction (Abingdon, England) [Addiction] 2019 Jan; Vol. 114 (1), pp. 189-190. Date of Electronic Publication: 2018 Oct 30. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9304118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1360-0443 (Electronic) Linking ISSN: 09652140 NLM ISO Abbreviation: Addiction Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
